Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +22.50%
#4 Bedrock Bedrock +19.73%
#5 Velvet Velvet +19.00%
#6 Fabric Protocol Fabric Protocol +16.39%
#7 Nockchain Nockchain +16.19%
#8 Perle Perle +13.72%
#9 Versatize Coin Versatize Coin +12.49%
#10 Starpower Starpower +12.07%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
株式のランク #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
株価
$0.00060315
最終同期: 2024-09-27
時価総額
$1.65M
変化（1日）
19.64%
変化（1年）
0.00%
国
SE
取引 Amniotics AB (publ) (AMNI)

カテゴリー

Healthcare
Amniotics AB (publ)（AMNI）の発行済株式数
December 2023 時点の発行済株式数 1.46B
Amniotics AB (publ) の最新の財務報告および株価によると、現在の発行済株式数は 1.46B です。December 2022 の終わりには、同社は 164.84M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Amniotics AB (publ)（AMNI）の発行済株式数の履歴（2018 ～ 2026）
各年末時点の発行済株式数
年 発行済株式数 変化
2026 (TTM) 1.46B -47.99%
2023 2.81B 1,602.50%
2022 164.84M 0.00%
2021 164.84M -10.30%
2020 183.76M 0.00%
2019 183.76M 0.00%
2018 183.76M 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数 差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -82.60%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -95.74%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE